Oklo stock tumbles as Financial Times scrutinizes valuation
DALLAS - Healthmine, a member engagement and rewards platform for health plans, has appointed Dwight Erskine as its new Chief Executive Officer, effective September 15, 2025, according to a company press release. The announcement comes as parent company Health Catalyst (HCAT) shows promising signs, with InvestingPro data indicating expected profitability for 2025 despite current market challenges.
Erskine succeeds Bryce Williams, who will remain with the company during a transition period before moving into an advisory role.
The new CEO brings over 25 years of experience in healthcare technology, transformation and analytics. He most recently served as Senior Vice President of Enterprise Transformation at VillageMD, where he led clinical operations streamlining efforts. Prior to that, Erskine was the healthcare leader at Synergetics, a global operations consulting firm.
"I’m honored to step into the role of CEO," Erskine said. "Healthmine is built on a powerful idea that when you engage people in meaningful ways, you can change their health and their lives."
Erskine joins Healthmine during what the company describes as a period of growth. In 2025, the company has launched several initiatives including AI-supported patient scheduling, improved in-home assessment connectivity, and strategic partnerships with Exact Sciences and Tenasol. According to InvestingPro analysis, Health Catalyst maintains a healthy current ratio of 1.83 and shows revenue growth of 5.55% over the last twelve months. Get deeper insights with InvestingPro’s comprehensive research reports, covering 1,400+ US stocks including Health Catalyst.
Charles Boorady, Founding Managing Partner at Health Catalyst Capital and Healthmine board member, said that under Williams’ leadership, "Healthmine has built a strong foundation and delivered significant value for health plans and members."
Healthmine provides a SaaS-based platform that helps health plans manage member relationships and engagement.
In other recent news, Health Catalyst has made several notable announcements and adjustments. The company appointed Ben Albert as President and Chief Operating Officer, following his previous role as CEO and Co-Founder of Upfront Healthcare Services, which Health Catalyst acquired in January. In a strategic move to enhance patient data exchange, Health Catalyst has partnered with CyncHealth Nebraska to improve the delivery and accuracy of patient health information. Analyst activity around Health Catalyst has been mixed, with Cantor Fitzgerald maintaining a Neutral rating and a $4.00 price target, while Canaccord Genuity lowered its price target to $5.00 from $9.00 but kept a Buy rating. Evercore ISI, on the other hand, raised its price target to $4.00 from $3.00, citing ongoing developments with the company’s Ignite platform. These recent developments reflect Health Catalyst’s efforts to adapt to the current healthcare environment and address growth concerns.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.